Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Volumn 33, Issue 4, 2012, Pages 1039-1044

  Cao, Y ^a   Shi, Yan xia ^b   Chen, Jing ou ^b   Tan, Yu ting ^b   Cai, Yu Chen ^b   Luo, Hui yan ^b   Qiu, Miao zhen ^b   Cai, Xiu yu ^b   Jin, Ying ^b   Sun, Yue li ^b   Jiang, Wen qi ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; KAPLAN MEIER METHOD; LARGE CELL LYMPHOMA; MALE; METABOLISM; MIDDLE AGED; OUTCOME ASSESSMENT; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STATISTICS;

ACUTE-PHASE PROTEINS; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; C-REACTIVE PROTEIN; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 85027947970     PISSN: None     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0337-z     Document Type: Article

References (0)